NCT05686785 Agreement and Reliability of Transient Elastography
| NCT ID | NCT05686785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lund University |
| Condition | Chronic Viral Hepatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-06-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess agreement, smallest detectable change, and reliability of repeated measurements of liver stiffness of transient elastography in patients with chronic viral hepatitis, and to explore factors associated with disagreement.
Eligibility Criteria
Inclusion Criteria: * Patients at the departments of infectious diseases in Malmö, Lund and Helsingborg with chronic viral hepatitis. * Adult patients * Signed informed consent to participate in the study. Exclusion Criteria: * suspected or confirmed pregnancy. * patients unable to speak Swedish * inability to sign informed consent.
Contact & Investigator
Oskar Ljungquist, MD, PhD.
PRINCIPAL INVESTIGATOR
Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund.
Frequently Asked Questions
Who can join the NCT05686785 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Viral Hepatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05686785 currently recruiting?
Yes, NCT05686785 is actively recruiting participants. Contact the research team at oskar.ljungquist@med.lu.se for enrollment information.
Where is the NCT05686785 trial being conducted?
This trial is being conducted at Helsingborg, Sweden.
Who is sponsoring the NCT05686785 clinical trial?
NCT05686785 is sponsored by Lund University. The principal investigator is Oskar Ljungquist, MD, PhD. at Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund.. The trial plans to enroll 300 participants.